The global platelet-rich plasma (PRP) market is witnessing rapid growth, driven by advancements in regenerative medicine, growing preference for non-invasive aesthetic procedures, and increased application in orthopedics and sports medicine. Valued at US$ 847.6 Mn in 2024, the market is forecast to grow at a robust CAGR of 9.6% from 2025 to 2035, crossing the US$ 2.3 Bn mark by the end of 2035,...